Stockscreener 앱 받기
152.89
4.29%
-6.85
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Charles River Laboratories International, Inc. (NYSE:CRL) Short Interest Up 37.9% in August - MarketBeat
Logan Capital Management Inc. Has $1.74 Million Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Cinctive Capital Management LP Reduces Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Charles River Laboratories International (CRL) Expands Oncology Partnerships With PICI and CHLA - simplywall.st
Charles River Laboratories International (NYSE:CRL) Shares Gap UpWhat's Next? - MarketBeat
Charles River Laboratories International, Inc. Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer - MarketScreener
Charles River Collaborates to Advance Novel Oncology Research & Development - Contract Pharma
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer - Business Wire
Gotham Asset Management LLC Increases Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Transcript : Charles River Laboratories International, Inc. Presents at Baird Global Healthcare Conference 2025, Sep-10-2025 09 - MarketScreener
Dynamic Technology Lab Private Ltd Boosts Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
Eminence Capital LP Sells 192,018 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International, Inc. $CRL Shares Bought by Royal Bank of Canada - MarketBeat
A Closer Look at Charles River Laboratories (CRL) Valuation Following Key Cell Therapy Platform Enhancement - simplywall.st
Charles River Labs stock rating upgraded by Jefferies on DSA bookings improvement - Investing.com Canada
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold (CRL) - Seeking Alpha
This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Evaluating Charles River Laboratories (CRL) Valuation Following New Cell Therapy Tech Integration - Yahoo Finance
CRL Stock Rating Upgraded to 'Buy' by Jefferies | CRL Stock News - GuruFocus
Charles River Laboratories International, Inc.'s (NYSE:CRL) Low P/S No Reason For Excitement - simplywall.st
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences - BioSpace
Charles River Laboratories to Present at Baird and Morgan Stanle - GuruFocus
What are the risks of holding Charles River Laboratories International Inc.July 2025 Update & Weekly High Conviction Ideas - beatles.ru
Ariel Investments LLC Purchases 33,449 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Is Charles River Laboratories International Inc. backed by strong institutional buyingTreasury Yields & Fast Exit and Entry Strategy Plans - beatles.ru
Canada Pension Plan Investment Board Buys 102,000 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
The Manufacturers Life Insurance Company Decreases Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
What’s the recovery path for long term holders of Charles River Laboratories International Inc.Profit Target & Consistent Profit Alerts - Newser
Measuring Charles River Laboratories International Inc.’s beta against major indicesMarket Trend Report & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-09-06 02:17:51 - خودرو بانک
Can Charles River Laboratories International Inc. lead its sector in growthTrade Exit Report & Expert Curated Trade Ideas - خودرو بانک
What are analysts’ price targets for Charles River Laboratories International Inc.July 2025 Levels & Free Weekly Watchlist of Top Performers - خودرو بانک
Why is Charles River Laboratories International Inc. stock going upWeekly Trend Recap & Stock Market Timing Techniques - خودرو بانک
Is Charles River Laboratories International Inc. likely to announce a buybackPortfolio Return Summary & Real-Time Volume Analysis - خودرو بانک
Is Charles River Laboratories International Inc. exposed to currency risks2025 Volatility Report & AI Enhanced Market Trend Forecasts - خودرو بانک
Sentiment analysis tools applied to Charles River Laboratories International Inc.2025 Performance Recap & Risk Managed Trade Strategies - Newser
How to read the order book for Charles River Laboratories International Inc.Market Growth Review & AI Driven Price Forecasts - Newser
Using AI based signals to follow Charles River Laboratories International Inc.Weekly Profit Report & Expert Approved Momentum Trade Ideas - Newser
Risk adjusted return profile for Charles River Laboratories International Inc. analyzed2025 Market Sentiment & Daily Profit Focused Screening - Newser
Leading vs lagging indicators on Charles River Laboratories International Inc. performanceJuly 2025 Volume & Verified High Yield Trade Plans - Newser
Tools to assess Charles River Laboratories International Inc.’s risk profilePortfolio Growth Summary & Stepwise Trade Execution Plans - Newser
Zacks Research Has Negative Estimate for CRL Q3 Earnings - MarketBeat
Does Charles River Laboratories International Inc. stock have upside surprise potentialJuly 2025 Outlook & AI Powered Market Trend Analysis - خودرو بانک
Applying Wyckoff theory to Charles River Laboratories International Inc. stock2025 Market Trends & Weekly Market Pulse Updates - Newser
Charles River Laboratories International Inc. stock trendline breakdownRecession Risk & Consistent Growth Stock Picks - Newser
Stock Analysis | Charles River Laboratories International OutlookMixed Signals Amid Diverging Analyst Views - AInvest
Strategies to average down on Charles River Laboratories International Inc.Earnings Recap Summary & Community Supported Trade Ideas - Newser
Is it the Right Time to Add CRL Stock to Your Portfolio Now? - sharewise.com
Risk vs reward if holding onto Charles River Laboratories International Inc.Earnings Risk Report & Fast Gain Swing Alerts - Newser
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences - BioSpace
Is Charles River Laboratories International Inc. stock bottoming outMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
What high frequency data says about Charles River Laboratories International Inc.July 2025 Short Interest & AI Driven Stock Reports - Newser
Price momentum metrics for Charles River Laboratories International Inc. explainedJuly 2025 Rallies & Comprehensive Market Scan Reports - Newser
Advanced analytics toolkit walkthrough for Charles River Laboratories International Inc.Market Trend Review & Real-Time Volume Analysis Alerts - Newser
How sentiment analysis helps forecast Charles River Laboratories International Inc.Sell Signal & Real-Time Volume Trigger Notifications - Newser
Has Charles River Laboratories International Inc. found a price floorPortfolio Value Report & Risk Managed Trade Strategies - Newser
Published on: 2025-09-03 22:41:58 - Newser
Statistical indicators supporting Charles River Laboratories International Inc.’s strengthPortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Technical analysis overview for Charles River Laboratories International Inc. stockWeekly Risk Report & Target Return Focused Picks - Newser
2.33%
자본화:
|
볼륨(24시간):